---
audienceLevel: patient
cancerTypes:
- bone
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- cancer-type
title: Bone Cancer Research - NCI
url: https://www.cancer.gov/types/bone/research
version: v1
---

# Bone Cancer Research - NCI

# Bone Cancer Research

- [ETV6 Protein Could Be an Important Target for Ewing Sarcoma Treatment](/news-events/cancer-currents-blog/2023/ewing-sarcoma-etv6-treatment-target)

Posted: March 7, 2023

The protein ETV6 appears to promote tumor growth by affecting the behavior of the EWS-FLI1 fusion protein that drives most Ewing sarcomas. The research groups that made the discovery hope it leads to a targeted therapy for the aggressive childhood cancer.
- [Ifosfamide May Be Treatment of Choice for Some People with Ewing Sarcoma, Trial Shows](/news-events/cancer-currents-blog/2022/ewing-sarcoma-chemotherapy-comparison)

Posted: July 8, 2022

New findings from the first large, randomized clinical trial to compare chemotherapy regimens for relapsed or treatment-resistant Ewing sarcoma could help doctors and patients select treatments.
- [NCI study provides genetic insights into osteosarcoma in children](/news-events/press-releases/2020/osteosarcoma-genetic-variants)

Posted: March 19, 2020

A new study offers insight into genetic alterations associated with osteosarcoma, the most common bone tumor of children and adolescents, and the findings have implications for genetic testing of children with osteosarcoma and their families.
- [Study Identifies Potential Drug Combination for Ewing Sarcoma](/news-events/cancer-currents-blog/2017/ewing-sarcoma-drug-combination)

Posted: November 9, 2017

From experiments in cells and mice, researchers have identified a two-drug combination that kills more Ewing sarcoma cells than either drug on its own. The study findings could help inform future clinical trials.
- [In Mice, New Drug Conjugate Suggests Promise for Hard-to-Treat Pediatric Cancers](/news-events/cancer-currents-blog/2015/hsp90-conjugate-sarcoma)

Posted: June 30, 2015

Findings from a study in mice suggests that a new type of drug conjugate may have potential as a treatment for two cancers that are often diagnosed in children.
